Skip to main content
    P

    Privia Health Group Inc (PRVA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $25.26
    +0.71 (+2.89%)

    Market Cap: $3.14B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Privia Health Group Inc (PRVA) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Privia Health Group reported revenue of $2.12B for the fiscal year ended Dec 31, 2025, up 22.3% from the year before. That year, net income was $29.73M with a net margin of 1.4%, operating cash flow was $163.40M and free cash flow was $162.20M. The quarter ended Sep 30, 2026 had revenue of $656.96M and net income of $14.59M.

    Revenue and Margins

    The operating margin was 1.6% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $657.61M, a compound annual rate of 18.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.12B+22.3%88.1%1.6%1.4%
    Dec 2024$1.74B+4.7%86.9%1.0%1.0%
    Dec 2023$1.66B+22.2%88.1%1.2%1.3%
    Dec 2022$1.36B+40.4%87.4%-1.4%-0.9%
    Dec 2021$966.22M+18.3%81.9%-22.5%-19.7%
    Dec 2020$817.08M+3.9%87.1%3.1%3.8%
    Dec 2019$786.36M+19.6%87.9%2.0%1.0%
    Dec 2018$657.61MN/A8.6%0.3%-0.5%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 74.5% from the year before. In the quarter ended Sep 2026, net income rose 48.7% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$2.12B$1.74B$1.66B$1.36B$966.22M$817.08M$786.36M$657.61M
    Cost of revenue$252.73M$227.00M$197.66M$170.84M$174.73M$105.01M$95.26M$601.15M
    Gross profit$1.87B$1.51B$1.46B$1.19B$791.49M$712.07M$691.10M$56.46M
    Operating income$34.23M$16.98M$20.65M-$19.12M-$217.44M$25.38M$16.06M$2.15M
    Net income$29.73M$17.04M$21.03M-$12.06M-$190.65M$30.90M$7.95M-$3.04M
    EBITDA$53.84M$35.14M$35.55M-$13.32M-$214.81M$27.34M$17.82M$3.23M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$656.96M$632.63M$603.85M$541.17M$580.42M$521.15M$480.10M$460.90M$437.92M$422.33M$415.24M$440.83M
    Gross profit$587.29M$563.27M$535.43M$474.32M$518.98M$456.24M$420.57M$401.13M$381.85M$365.22M$361.19M$388.42M
    Operating income$20.54M$11.77M$7.42M$11.28M$14.40M$3.34M$5.22M$5.25M$5.81M$5.10M$823.00K$1.42M
    Net income$14.59M$9.73M$3.71M$10.59M$9.81M$3.29M$6.05M$5.37M$3.98M$4.64M$3.06M$2.32M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $2.20M by $477.49M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$1.37B$1.14B$999.90M$792.81M$686.37M$328.97M$270.20M$249.49M
    Current assets$911.00M$834.82M$700.80M$551.96M$446.68M$190.08M$129.60M$115.49M
    Cash and equivalents$479.69M$491.15M$389.51M$347.99M$320.58M$84.63M$46.89M$39.11M
    Total liabilities$578.43M$452.34M$392.51M$273.76M$236.19M$185.32M$162.75M$163.44M
    Short-term debt$2.20M$2.55M$3.04M$3.01M$875.00K$875.00K$3.38M$7.13M
    Long-term debtN/AN/AN/AN/A$31.69M$32.78M$39.73MN/A
    Shareholder equity$737.22M$635.18M$561.44M$499.09M$426.87M$146.75M$110.21M$88.50M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.56B$1.49B$1.42B$1.37B$1.35B$1.27B$1.18B$1.14B$1.15B$1.08B$1.03B$999.90M
    Total liabilities$690.80M$650.51M$611.99M$578.43M$588.23M$539.00M$474.01M$452.34M$483.38M$434.01M$408.76M$392.51M
    Cash and equivalents$446.28M$412.20M$419.52M$479.69M$441.35M$390.13M$469.33M$491.15M$422.00M$387.35M$351.14M$389.51M
    Shareholder equity$815.72M$782.33M$753.06M$737.22M$709.12M$682.86M$659.44M$635.18M$614.89M$595.41M$576.80M$561.44M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 99.3% of operating cash flow. Dividends came to 0.8% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow$163.40M$109.28M$80.78M$47.20M$55.06M$38.89M$24.36M$5.25M
    Capital expenditures$1.20M$5.02M$113.00K$104.00K$547.00K$380.00K$5.71M$220.00K
    Free cash flow$162.20M$104.26M$80.67M$47.09M$54.51M$38.51M$18.65M$5.03M
    Dividends paid$1.34M$0$5.69M$0$0N/AN/AN/A
    Share repurchasesN/AN/AN/AN/A$12.69M$0$0N/A
    Investing cash flow-$181.57M-$11.98M-$42.97M-$104.00K-$32.77M-$380.00K-$5.71M-$165.00K
    Financing cash flow$6.70M$4.33M$3.71M-$19.68M$213.66M-$767.00K-$10.87M$15.36M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$28.94M$1.10M-$49.47M$127.50M$51.99M$7.97M-$24.06M$74.80M$33.15M$34.47M-$33.14M$64.10M
    Capital expendituresN/AN/A$26.00K$1.20M$1.20M$0$0$15.00K$5.01M$0$5.01M$23.00K
    Free cash flowN/AN/A-$49.49M$126.30M$50.79M$7.97M-$24.06M$74.78M$28.15M$34.47M-$38.14M$64.08M
    Last 12 quarters

    Frequently Asked Questions About PRVA

    What is Privia Health Group's annual revenue?

    Privia Health Group reported revenue of $2.12B for the fiscal year ended Dec 31, 2025.

    How fast is Privia Health Group's revenue growing?

    Revenue was up 22.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 16.1%.

    Is Privia Health Group profitable?

    Yes. Privia Health Group reported net income of $29.73M for the fiscal year ended Dec 31, 2025, with a net margin of 1.4%.

    How much free cash flow does PRVA generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $163.40M minus capital expenditures of $1.20M produced free cash flow of $162.20M.

    How much debt does Privia Health Group have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $2.20M and cash and equivalents of $479.69M.